FLSM
ALPN
Frazier Life Sciences Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,131,008
| Closed | -$124M | – | 57 |
|
|
2024
Q1 | $124M | Hold |
3,131,008
| – | – | 5.24% | 5 |
|
|
2023
Q4 | $59.7M | Buy |
3,131,008
+145,251
| +5% | +$2.77M | 3.19% | 10 |
|
|
2023
Q3 | $34.2M | Hold |
2,985,757
| – | – | 2.27% | 12 |
|
|
2023
Q2 | $30.7M | Hold |
2,985,757
| – | – | 1.83% | 14 |
|
|
2023
Q1 | $23.1M | Hold |
2,985,757
| – | – | 1.67% | 14 |
|
|
2022
Q4 | $21.9M | Hold |
2,985,757
| – | – | 1.36% | 19 |
|
|
2022
Q3 | $21.5M | Hold |
2,985,757
| – | – | 1.66% | 18 |
|
|
2022
Q2 | $25.4M | Sell |
2,985,757
-1,200,000
| -29% | -$10.2M | 2.4% | 13 |
|
|
2022
Q1 | $37.5M | Buy |
+4,185,757
| New | +$37.5M | 3.2% | 11 |
|